Clinical Trials

A Phase 3, Randomized, Double-blind, Placebo-Controlled, Multicenter Study of ABSK021 to Assess the Efficacy and Safety in Patients With Tenosynovial Giant Cell Tumor

Link : https://clinicaltrials.gov/ct2/show/NCT05804045
Status : CLOSED
Population : PVNS/TCGT
Description : ABSK021 (CSF-1R) vs. placebo
PI : A. Razak
Centers Opened : TBD
Phase : III
IIST/Pharma : Pharma